Gareth Sullivan
Gareth is a group leader within the Norwegian Center for Stem Cell Research and a PI within the Hybrid Technology Hub – Centre of Excellence in Oslo.
He holds a PhD in molecular cell biology from the University of Dundee, Scotland and performed his post-doctoral research at the Centre of Regenerative Medicine, University of Edinburgh with Sir Prof. Ian Wilmut. In addition he has over 8 years industrial experience, as a CSO, working in both the toxicology and next generation sequencing fields. At the end of 2011 he established his own research group at the University of Oslo and Oslo University Hospital. His research focus turned to what dictates cellular fate decision, along with the utilization of induced pluripotent stem cells to study disease in the dish. The overall focus of the lab now is the development of tissue models using human pluripotent stem cells that reflect the in vivo organ, thus allowing the dissection of disease, provide tools to investigate toxicology, reduce drug failure rates and importantly enable regenerative medicine.
More recently his lab has embarked on utilizing what has been gleaned from human pluripotent stem cell research to address a critical barrier preventing the acceleration of clean meat research, that is the availability of relevant cell lines. The group are applying their know-how of directing human pluripotent stem cell fate to animal pluripotent stem cell models. This repository will potentially safeguard these animals existence, providing cellular sources for clean meat and the tools to investigate disease in the dish specific to the species.
